Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model
© 2024. The Author(s), under exclusive licence to American Aging Association..
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still an ongoing global health crisis. Clinical data indicate that the case fatality rate (CFR) is age dependent, with a higher CFR percentage in the elderly population. We compared the pathogenesis of SARS-CoV-2 in young and aged K18-hACE2 transgenic mice. We evaluated morbidity, mortality, viral titers, immune responses, and histopathology in SARS-CoV-2-infected young and old K18-hACE2 transgenic mice. Within the limitation of having a low number of mice per group, our results indicate that SARS-CoV-2 infection resulted in slightly higher morbidity, mortality, and viral replication in the lungs of old mice, which was associated with an impaired IgM response and altered cytokine and chemokine profiles. Results of this study increase our understanding of SARS-CoV-2 infectivity and immuno-pathogenesis in the elderly population.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
GeroScience - 46(2024), 3 vom: 22. Apr., Seite 2901-2913 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dwivedi, Varun [VerfasserIn] |
---|
Links: |
---|
Themen: |
ACE2 protein, human |
---|
Anmerkungen: |
Date Completed 15.04.2024 Date Revised 25.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11357-024-01102-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368789020 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368789020 | ||
003 | DE-627 | ||
005 | 20240426233740.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11357-024-01102-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n1388.xml |
035 | |a (DE-627)NLM368789020 | ||
035 | |a (NLM)38388916 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Dwivedi, Varun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.04.2024 | ||
500 | |a Date Revised 25.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s), under exclusive licence to American Aging Association. | ||
520 | |a Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still an ongoing global health crisis. Clinical data indicate that the case fatality rate (CFR) is age dependent, with a higher CFR percentage in the elderly population. We compared the pathogenesis of SARS-CoV-2 in young and aged K18-hACE2 transgenic mice. We evaluated morbidity, mortality, viral titers, immune responses, and histopathology in SARS-CoV-2-infected young and old K18-hACE2 transgenic mice. Within the limitation of having a low number of mice per group, our results indicate that SARS-CoV-2 infection resulted in slightly higher morbidity, mortality, and viral replication in the lungs of old mice, which was associated with an impaired IgM response and altered cytokine and chemokine profiles. Results of this study increase our understanding of SARS-CoV-2 infectivity and immuno-pathogenesis in the elderly population | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Aging | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Cytokine storm | |
650 | 4 | |a K18-hACE2 transgenic mouse | |
650 | 4 | |a SARS-CoV-2 infection | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a ACE2 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
650 | 7 | |a Immunoglobulin M |2 NLM | |
700 | 1 | |a Shivanna, Vinay |e verfasserin |4 aut | |
700 | 1 | |a Gautam, Shalini |e verfasserin |4 aut | |
700 | 1 | |a Delgado, Jennifer |e verfasserin |4 aut | |
700 | 1 | |a Hicks, Amberlee |e verfasserin |4 aut | |
700 | 1 | |a Argonza, Marco |e verfasserin |4 aut | |
700 | 1 | |a Meredith, Reagan |e verfasserin |4 aut | |
700 | 1 | |a Turner, Joanne |e verfasserin |4 aut | |
700 | 1 | |a Martinez-Sobrido, Luis |e verfasserin |4 aut | |
700 | 1 | |a Torrelles, Jordi B |e verfasserin |4 aut | |
700 | 1 | |a Kulkarni, Viraj |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t GeroScience |d 2017 |g 46(2024), 3 vom: 22. Apr., Seite 2901-2913 |w (DE-627)NLM26925417X |x 2509-2723 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2024 |g number:3 |g day:22 |g month:04 |g pages:2901-2913 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11357-024-01102-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2024 |e 3 |b 22 |c 04 |h 2901-2913 |